These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 712499)

  • 1. Long-term colchicine therapy of familial Mediterranean fever.
    Lehman TJ; Peters RS; Hanson V; Schwabe A
    J Pediatr; 1978 Nov; 93(5):876-8. PubMed ID: 712499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term colchicine treatment in children with familial Mediterranean fever.
    Zemer D; Livneh A; Danon YL; Pras M; Sohar E
    Arthritis Rheum; 1991 Aug; 34(8):973-7. PubMed ID: 1859491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term colchicine prophylaxis in children with familial Mediterranean fever (recurrent hereditary polyserositis).
    Majeed HA; Carroll JE; Khuffash FA; Hijazi Z
    J Pediatr; 1990 Jun; 116(6):997-9. PubMed ID: 2112191
    [No Abstract]   [Full Text] [Related]  

  • 4. Colchicine use for familial Mediterranean fever. Observations associated with long-term treatment.
    Peters RS; Lehman TJ; Schwabe AD
    West J Med; 1983 Jan; 138(1):43-6. PubMed ID: 6837018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of intravenous Colchicine in children with Familial Mediterranean Fever.
    Tal R; Semo Oz R; Amarilyo G; Eidlitz-Marcus T; Goldberg O; Levinsky Y; Peled O; Harel L
    Rheumatol Int; 2020 Jan; 40(1):121-128. PubMed ID: 31230112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of long-term treatment with intravenous colchicine for familial Mediterranean fever (FMF) refractory to oral colchicine.
    Grossman C; Farberov I; Feld O; Livneh A; Ben-Zvi I
    Rheumatol Int; 2019 Mar; 39(3):517-523. PubMed ID: 30604205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement.
    Kallinich T; Haffner D; Niehues T; Huss K; Lainka E; Neudorf U; Schaefer C; Stojanov S; Timmann C; Keitzer R; Ozdogan H; Ozen S
    Pediatrics; 2007 Feb; 119(2):e474-83. PubMed ID: 17242135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK; Beşbaş N; Topaloglu R; Ozen S
    Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colchicine treatment in children with familial Mediterranean fever.
    Ozkaya N; Yalçinkaya F
    Clin Rheumatol; 2003 Oct; 22(4-5):314-7. PubMed ID: 14579163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of intermittent colchicine therapy in familial Mediterranean fever.
    Wright DG; Wolff SM; Fauci AS; Alling DW
    Ann Intern Med; 1977 Feb; 86(2):162-5. PubMed ID: 319724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of colchicine and disease severity on physical growth in children with familial Mediterranean fever.
    Yoldaş TÇ; Çakar N; Başaran Ö; Acar B; Uncu N; Çaycı FŞ
    Clin Rheumatol; 2016 Jun; 35(6):1603-7. PubMed ID: 26384820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily use of colchicine in children with familial Mediterranean fever.
    Koşan C; Ozkan B
    Clin Pediatr (Phila); 2004 Sep; 43(7):605-8. PubMed ID: 15378145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled trial of colchicine in preventing attacks of familial mediterranean fever.
    Zemer D; Revach M; Pras M; Modan B; Schor S; Sohar E; Gafni J
    N Engl J Med; 1974 Oct; 291(18):932-4. PubMed ID: 4606109
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma colchicine concentration in patients with recurrent polyserositis (familial Mediterranean fever) on long-term prophylaxis.
    Katz EZ; Ehrenfeld M; Levy M; Eliakim M
    Arthritis Rheum; 1982 Feb; 25(2):227-31. PubMed ID: 7066054
    [No Abstract]   [Full Text] [Related]  

  • 15. Interventions for reducing inflammation in familial Mediterranean fever.
    Wu B; Xu T; Li Y; Yin X
    Cochrane Database Syst Rev; 2015 Mar; (3):CD010893. PubMed ID: 25791871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do all colchicine preparations have the same effectiveness in patients with familial Mediterranean fever?
    Baglan E; Ozdel S; Bulbul M
    Mod Rheumatol; 2021 Mar; 31(2):481-484. PubMed ID: 32613873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
    Koga T; Sato S; Miyamoto J; Hagimori N; Kawazoe Y; Arinaga K; Fukushima C; Yamamoto H; Kawakami A
    Trials; 2018 Dec; 19(1):715. PubMed ID: 30594222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an update.
    Cerquaglia C; Diaco M; Nucera G; La Regina M; Montalto M; Manna R
    Curr Drug Targets Inflamm Allergy; 2005 Feb; 4(1):117-24. PubMed ID: 15720245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patients.
    Calguneri M; Apras S; Ozbalkan Z; Ozturk MA; Ertenli I; Kiraz S
    Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S41-4. PubMed ID: 15515783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Colchicine-aspirin for recurrent polyserositis (familial Mediterranean fever).
    Eliakim M; Light A
    Lancet; 1973 Dec; 2(7841):1333. PubMed ID: 4127683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.